TY - JOUR
AU - Bhat RM
AU - Vaidya T
AB - Erythema nodosum leprosum (ENL) is a manifestation of type II lepra reaction, seen in lepromatous or borderline lepromatous leprosy. Although it is a common reaction encountered in clinical practice, there are an increasingly large number of newer updates in the pathophysiology and management of this condition.The treatment options have expanded far beyond just thalidomide and steroids and now extends to TNF-α inhibitors, thalidomide analogs, tenidap, cyclosporine A, plasma exchange, and even IVIG amongst others. These updates and the current knowledge of ENL are summarized in this review.
BT - Indian Dermatology Online Journal
LA - eng
N2 - Erythema nodosum leprosum (ENL) is a manifestation of type II lepra reaction, seen in lepromatous or borderline lepromatous leprosy. Although it is a common reaction encountered in clinical practice, there are an increasingly large number of newer updates in the pathophysiology and management of this condition.The treatment options have expanded far beyond just thalidomide and steroids and now extends to TNF-α inhibitors, thalidomide analogs, tenidap, cyclosporine A, plasma exchange, and even IVIG amongst others. These updates and the current knowledge of ENL are summarized in this review.
PY - 2020
SP - 482
EP - 492
T2 - Indian Dermatology Online Journal
TI - What is new in the pathogenesis and management of erythema nodosum leprosum
UR - http://www.idoj.in/temp/IndianDermatolOnlineJ114482-3755472_102554.pdf
VL - 4
ER -